Coinfección/sobreinfección fúngica en pacientes con COVID-19 en un hospital de tercer nivel en México
Resumen
Introduction. Data on the prevalence of fungal coinfections/superinfections in patients with COVID-19 are limited.
Objective. To describe the prevalence of fungal coinfections/superinfections in patients with COVID-19, as well as risk factors and demographic, clinical, and microbiological characteristics in a tertiary hospital in Mexico.
Material and methods. Patients with a confirmed COVID-19 diagnosis and a confirmed fungal infection hospitalized in the ICU from March 2020–December 2021 were included. Data on age, sex, comorbidities, hospital length of stay (days), laboratory (ferritin) and microbiological results, treatment for COVID-19, antifungal therapy, and outcome were obtained from the clinical record.
Results. 11/740 patients met the inclusion criteria. The coinfection and superinfection rates were 0.3% and 1.2%, respectively. The most affected population was male adults. The coinfections/superinfections diagnosed were candiduria and candidemia, caused by Candida albicans, C. tropicalis, C. glabrata, C. lusitaniae, and Kluyveromyces marxianus (C. kefyr). In addition, tracheobronchitis due to Aspergillus fumigatus was found. The most used antifungals were fluconazole and caspofungin. The lethality in patients with fungal coinfections and superinfections was 50% and 22%, respectively. The length of hospital stay was 11-65 days. Eight patients required mechanical ventilation and six received corticosteroids. The main comorbidity was diabetes mellitus (81.8%).
Conclusions. The rate of fungal coinfections/superinfections in COVID-19 patients was low, but the lethality found urges for routine fungal screening in patients with severe COVID-19 to timely detect fungal infections that may further compromise the patient's life.
Descargas
Algunos artículos similares:
- Jorge Alberto Cortés, José Franklin Ruiz, Lizeth Natalia Melgarejo-Moreno, Elkin V. Lemos, Candidemia en Colombia , Biomédica: Vol. 40 Núm. 1 (2020)
- Juan Manuel Senior, Clara Saldarriaga, Endocarditis infecciosa por Paecilomyces variotii , Biomédica: Vol. 29 Núm. 2 (2009)
- Carolina Firacative, Germán Torres, María Claudia Rodríguez, Patricia Escandón, Primer aislamiento ambiental de Cryptococcus gattii de serotipo B, en Cúcuta, Colombia , Biomédica: Vol. 31 Núm. 1 (2011)
- Husein Husein-El Ahmed, Guillermo Arturo Cañadas-De la Fuente, Rafael Fernández-Castillo, Emilio González-Jiménez, Jesús Cantero-Hinojosa, Marita Lardón-Fernández, Candidiasis cutánea generalizada en recién nacido a término , Biomédica: Vol. 32 Núm. 2 (2012)
- Angélica Ballesteros, Sandra Beltrán, Jaime Patiño, Cynthia Bernal, Rocío Orduz, Paracoccidioidomicosis juvenil diseminada diagnosticada en una niña en área urbana , Biomédica: Vol. 34 Núm. 1 (2014)
- Natalia Osorio, Yúrika López, Juan Camilo Jaramillo, Histoplasmosis del sistema nervioso central en un paciente inmunocompetente , Biomédica: Vol. 34 Núm. 4 (2014)
- José Humberto Bravo, Andrés Mauricio Agudelo, Armando Cortés, Lorena Matta, Mucormicosis rino-órbito-cerebral de origen dental , Biomédica: Vol. 38 Núm. 1 (2018)
- Julián Alfredo Fernández-Niño , Andrés Cubillos , Ietza Bojórquez , Michael Rodríguez , Recomendaciones para la respuesta contra la COVID-19 en contextos migratorios bajo una frontera cerrada: el caso de Colombia , Biomédica: Vol. 40 Núm. Supl. 2 (2020): SARS-CoV-2 y COVID-19
- Paola Macías , Juliana Ordóñez , Claudia M. Arenas , Gerzaín Rodríguez , Hombre de 18 años con síndrome verrugoso tropical: ¿leishmaniasis o esporotricosis? , Biomédica: Vol. 41 Núm. 2 (2021)
- Claudia Milena Cuéllar-Segura, Lecciones aprendidas en salud pública frente a la COVID-19: una mirada hacia futuras epidemias y pandemias , Biomédica: Vol. 42 Núm. Sp. 2 (2022): Covid-19
Derechos de autor 2024 Biomédica
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
Estadísticas de artículo | |
---|---|
Vistas de resúmenes | |
Vistas de PDF | |
Descargas de PDF | |
Vistas de HTML | |
Otras vistas |